Robin Carr
Vorstandsvorsitzender bei Myricx Pharma Ltd.
Ursprung des Netzwerks ersten Grades von Robin Carr
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia.
31
| Private Company | Investment Managers | 31 |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California.
16
| Subsidiary | Investment Managers | 16 |
Myricx Pharma Ltd.
Myricx Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Myricx Pharma Ltd. engages in the development of novel proprietary inhibitors of human N-myristoyltransferases. The company was founded by Ed Tate, Roberto Solari, and Andrew Bell in 2019 and is headquartered in Stevenage, the United Kingdom.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Robin Carr
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One Capital Management LP (SR One) is a venture capital firm founded in 2020. The firm is headquartered in Redwood, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Consultant / Advisor Chief Executive Officer Private Equity Investor Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Director/Board Member Private Equity Investor Compliance Officer Director of Finance/CFO Comptroller/Controller/Auditor | |
Asceneuron SA
Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Chairman Director/Board Member Private Equity Investor | |
Touchstone Innovations Investment Management Ltd.
Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London. | Investment Managers | Private Equity Analyst Director/Board Member Private Equity Investor | |
Imperial College London | College/University | Masters Business Admin Masters Business Admin Corporate Officer/Principal | |
University of Cambridge | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
Global Kinetics Pty Ltd.
Global Kinetics Pty Ltd. Medical SpecialtiesHealth Technology Global Kinetics Pty Ltd. provides point of care measurement and reporting of Parkinson's disease motor symptoms. Its product includes Personal KinetiGraph (PKG), a wrist worn medical device which reminds the patient when they have taken Levodopa medication as prescribed by doctor. The company was founded by Robert Griffiths and Malcolm Horne in 2007 and is headquartered in Melbourne, Australia. | Medical Specialties | Chairman Director/Board Member Director/Board Member | |
PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Operating Officer | |
University of Oxford | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Pathios Therapeutics Ltd.
Pathios Therapeutics Ltd. BiotechnologyHealth Technology Pathios Therapeutics Ltd. engages in discovering and developing novel small molecule drugs. The company was founded by Thomas David McCarthy, Alan Naylor, Kirsty McCarthy, Peter Joyce and Someit Sidhu in 2017 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member Founder Founder | |
Respirion Pharmaceuticals Pty Ltd.
Respirion Pharmaceuticals Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Respirion Pharmaceuticals Pty Ltd. operates as a biotechnology firm. It focuses on development new treatments for respiratory diseases. The company was founded by Barry Clements in 2018 and is headquartered in Iluka, Australia. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
OncoRes Medical Pty Ltd.
OncoRes Medical Pty Ltd. Medical SpecialtiesHealth Technology OncoRes Medical Pty Ltd. develops an imaging medical device which provides micro-scale images of tissue stiffness and elasticity information to surgeons. The company is headquartered in Nedlands, Australia. | Medical Specialties | Chairman Chief Executive Officer | |
Dren Bio, Inc.
Dren Bio, Inc. BiotechnologyHealth Technology Dren Bio, Inc. operates as a biotechnology company. It focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents. The company was founded by John Wesley and Nenad Tomasevic in 2019 and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member Director/Board Member | |
University of Adelaide | College/University | Graduate Degree Doctorate Degree | |
University College London | College/University | Doctorate Degree Doctorate Degree | |
The Johns Hopkins University | College/University | Undergraduate Degree Graduate Degree | |
Denteric Pty Ltd.
Denteric Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Denteric Pty Ltd. is a biotechnology company focused on oral health. It provides developing vaccines for treating and preventing severe periodontal disease. The company was founded by Eric C. Reynolds and is headquartered in Melbourne, Australia. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
MiroBio Ltd.
MiroBio Ltd. BiotechnologyHealth Technology Mirobio Ltd. operates as a biologics company focusing on autoimmune and inflammatory disorders. The firm develops antibody modulators of immune cell receptors, an approach that has potential across a range of diseases, with an initial focus on auto-immune disease. The company was founded by Richard Cornall and Simon Davis on October 8, 2018 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member Chairman | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
HotSpot Therapeutics, Inc.
HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA. | Biotechnology | Director/Board Member Director/Board Member | |
CRISPR THERAPEUTICS AG | Biotechnology | Chief Executive Officer Director/Board Member | |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
QUE Oncology, Inc.
QUE Oncology, Inc. Pharmaceuticals: MajorHealth Technology QUE Oncology, Inc. engages in preventing and treating life-threatening cancers such as prostate cancer, breast cancer, melanoma, and cancer pain; and related conditions. The company is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Doctorate Degree Graduate Degree | |
Second Genome, Inc.
Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Cardiora Pty Ltd.
Cardiora Pty Ltd. Investment Trusts/Mutual FundsMiscellaneous Cardiora Pty Ltd. functions as a clinical stage pharmaceutical company. It develops CRD-102, an oral medicine for heart failure. The company was founded by David Kaye in 2015 and is headquartered in Melbourne, Australia. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Founder | |
Molecular Vision Ltd.
Molecular Vision Ltd. Medical SpecialtiesHealth Technology Molecular Vision Ltd. develops low-cost, lab-quality, point of care, disposable diagnostic devices for medical testing. The company was founded by Donal D. C. Bradley in 2001 and is headquartered in York, the United Kingdom. | Medical Specialties | Director/Board Member Director/Board Member | |
IlluminOss Medical, Inc.
IlluminOss Medical, Inc. Medical SpecialtiesHealth Technology IlluminOss Medical, Inc. engages in the designing, developing, and marketing of orthopedic fracture repair products. The company was founded by Robert A. Rabiner and Arnold-Peter C. Weiss in 2007 and is headquartered in East Providence, RI. | Medical Specialties | Director/Board Member Director/Board Member | |
TOUCHSTONE INNOVATIONS PLC | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Simcha Therapeutics, Inc.
Simcha Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Simcha Therapeutics, Inc. operates as a biopharmaceutical company that develops engineered interleukin therapy products. The company was founded by Aaron Ring in 2018 and is headquartered in New Haven, CT. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Simcha Therapeutics Holding Co. LLC
Simcha Therapeutics Holding Co. LLC BiotechnologyHealth Technology Simcha Therapeutics Holding Co. LLC is a biopharmaceutical company which engages in developing an engineered interleukin therapy. The company was founded in 2018 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member Chairman | |
Elastagen Pty Ltd.
Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | Medical Specialties | Director/Board Member Chief Executive Officer | |
NKARTA, INC. | Biotechnology | Director/Board Member Director/Board Member | |
DESIGN THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Stanford University | College/University | Doctorate Degree Doctorate Degree | |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Apax Partners LLP
Apax Partners LLP Investment ManagersFinance Apax Partners LLP engages in providing investment services. It focuses on investing in firms across the global sectors such as technology and telecommunications, services, healthcare, and consumer. The company was founded by Ronald Mourad Cohen and Alan J. Patricof in 1969 and is headquartered in London, the United Kingdom. | Investment Managers | Director/Board Member Private Equity Investor | |
EBR SYSTEMS, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
Australian Biomedical Fund No. 1 Ltd.
Australian Biomedical Fund No. 1 Ltd. Investment ManagersFinance Australian Biomedical Fund No. 1 Ltd. invests in emerging life sciences companies located in Australia. The fund focuses on biotechnology & healthcare companies operating in the fields of pharmaceutical products & services, medical devices, e-commerce applications and computer software. It provides financing for start ups and early stage capital requirements. It also considers co-investments with other funds or private investors. | Investment Managers | Director/Board Member |
Statistik
International
Vereinigte Staaten | 22 |
Vereinigtes Königreich | 14 |
Australien | 13 |
Schweiz | 3 |
Israel | 2 |
Sektoral
Health Technology | 31 |
Consumer Services | 11 |
Finance | 6 |
Commercial Services | 5 |
Miscellaneous | 2 |
Operativ
Director/Board Member | 225 |
Corporate Officer/Principal | 73 |
Private Equity Investor | 55 |
Independent Dir/Board Member | 37 |
Chairman | 34 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Julie Cherrington | 32 |
J. Read | 27 |
Deborah Harland | 27 |
Maina Bhaman | 26 |
Chris Nave | 24 |
Jake Bauer | 24 |
Rajeev Dadoo | 24 |
Simeon George | 23 |
Jonathan Leslie Tobin | 19 |
Jill Carroll | 19 |
Stephen Thompson | 18 |
Christopher Martin | 18 |
Peter van Vlasselaer | 15 |
Heather Behanna | 15 |
Matthew Foy | 13 |
- Börse
- Insiders
- Robin Carr
- Unternehmensverbindungen